ArticleEuropean journal of nuclear medicine and molecular imaging2011

Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.

Roy Moncayo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.